Vir Biotechnology (VIR) Stock: Why It's Up Today
Updated Oct 19, 2026, 11:42 AM ET · intraday price
- Trading at $10.17 as of 11:42 AM ET, +2.11% vs the prior close of $9.96.
- Volume 361.38K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
VIR rises 2.1% to $10.17. Trading at $10.17 (intraday, 11:42 AM ET), +2.11% vs the prior close of $9.96. Day range $9.96–$10.23, opened at $10.07.
VIR daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — VIR rises 2.1% to $10.17
- Trading at $10.17 (intraday, 11:42 AM ET), +2.11% vs the prior close of $9.96. Day range $9.96–$10.23, opened at $10.07.
- Volume was 361.38K shares, 0.2x its 50-day average of 2.04M — lighter than usual.
- Price is -4.1% vs its 50-day average ($10.60) and +9.4% vs its 200-day average ($9.29).
- 52-week range $4.82–$12.00; the current price sits at 75% of that range, 15.2% below the 52-week high.
Oct 16, 2026 — VIR slides 4.9% to $9.96, a 1-month low
- Closed at $9.96, -4.87% vs the prior close of $10.47. Day range $9.91–$10.45, opened at $10.45.
- Volume was 1.74M shares, 0.8x its 50-day average of 2.05M.
- Price is -5.8% vs its 50-day average ($10.58) and +7.4% vs its 200-day average ($9.27).
- 52-week range $4.82–$12.00; today's close sits at 72% of that range, 17.0% below the 52-week high.
Oct 15, 2026 — VIR rises 0.6% to $10.47
- Closed at $10.47, +0.58% vs the prior close of $10.41. Day range $10.20–$10.67, opened at $10.38.
- Volume was 1.42M shares, 0.7x its 50-day average of 2.05M.
- Price is -0.8% vs its 50-day average ($10.55) and +13.1% vs its 200-day average ($9.25).
- 52-week range $4.82–$12.00; today's close sits at 79% of that range, 12.7% below the 52-week high.
Oct 14, 2026 — VIR dips 1.9% to $10.41, a 1-month low, 3 down days in a row
- Closed at $10.41, -1.89% vs the prior close of $10.61. Day range $10.34–$11.11, opened at $10.95.
- Volume was 2.76M shares, 1.4x its 50-day average of 2.03M.
- Price is -1.1% vs its 50-day average ($10.52) and +12.8% vs its 200-day average ($9.23).
- 52-week range $4.82–$12.00; today's close sits at 78% of that range, 13.3% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 13, 2026 — VIR slides 6.1% to $10.61
- Closed at $10.61, -6.11% vs the prior close of $11.30. Day range $10.60–$11.25, opened at $11.21.
- Volume was 1.78M shares, 0.9x its 50-day average of 2.02M.
- Price is +1.1% vs its 50-day average ($10.50) and +15.2% vs its 200-day average ($9.21).
- 52-week range $4.82–$12.00; today's close sits at 81% of that range, 11.6% below the 52-week high.
Oct 12, 2026 — VIR slides 3.4% to $11.30
- Closed at $11.30, -3.42% vs the prior close of $11.70. Day range $11.21–$11.82, opened at $11.63.
- Volume was 1.09M shares, 0.5x its 50-day average of 2.02M — lighter than usual.
- Price is +8.0% vs its 50-day average ($10.47) and +23.0% vs its 200-day average ($9.19).
- 52-week range $4.82–$12.00; today's close sits at 90% of that range, 5.8% below the 52-week high.
Oct 9, 2026 — VIR jumps 5.2% to $11.70
- Closed at $11.70, +5.22% vs the prior close of $11.12. Day range $10.97–$12.00, opened at $11.11.
- Volume was 1.97M shares, 1.0x its 50-day average of 2.01M.
- Price is +12.4% vs its 50-day average ($10.41) and +27.7% vs its 200-day average ($9.16).
- 52-week range $4.82–$12.00; today's close sits at 96% of that range, 2.5% below the 52-week high.
Oct 8, 2026 — VIR slides 3.5% to $11.12, 3 down days in a row
- Closed at $11.12, -3.47% vs the prior close of $11.52. Day range $10.73–$11.56, opened at $11.52.
- Volume was 3.07M shares, 1.6x its 50-day average of 1.97M.
- Price is +7.4% vs its 50-day average ($10.36) and +21.8% vs its 200-day average ($9.13).
- 52-week range $4.82–$11.94; today's close sits at 88% of that range, 6.9% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 7, 2026 — VIR dips 0.7% to $11.52 on 1.8x normal volume
- Closed at $11.52, -0.69% vs the prior close of $11.60. Day range $11.32–$11.77, opened at $11.32.
- Volume was 3.56M shares, 1.8x its 50-day average of 1.93M — unusually heavy trading.
- Price is +11.8% vs its 50-day average ($10.31) and +26.5% vs its 200-day average ($9.10).
- 52-week range $4.82–$11.94; today's close sits at 94% of that range, 3.5% below the 52-week high.
Oct 6, 2026 — VIR dips 1.5% to $11.60
- Closed at $11.60, -1.53% vs the prior close of $11.78. Day range $11.26–$11.90, opened at $11.90.
- Volume was 2.59M shares, 1.4x its 50-day average of 1.91M.
- Price is +13.1% vs its 50-day average ($10.25) and +27.8% vs its 200-day average ($9.08).
- 52-week range $4.82–$11.94; today's close sits at 95% of that range, 2.8% below the 52-week high.
Oct 5, 2026 — VIR jumps 5.5% to $11.78, a 52-week high
- Closed at $11.78, +5.46% vs the prior close of $11.17. Day range $10.92–$11.87, opened at $11.17.
- Volume was 3.15M shares, 1.7x its 50-day average of 1.89M.
- Price is +15.5% vs its 50-day average ($10.20) and +30.2% vs its 200-day average ($9.05).
- 52-week range $4.82–$11.94; today's close sits at 98% of that range, 1.3% below the 52-week high.
Oct 2, 2026 — VIR dips 1.1% to $11.17
- Closed at $11.17, -1.06% vs the prior close of $11.29. Day range $10.95–$11.73, opened at $11.55.
- Volume was 2.18M shares, 1.2x its 50-day average of 1.88M.
- Price is +10.2% vs its 50-day average ($10.14) and +23.8% vs its 200-day average ($9.02).
- 52-week range $4.82–$11.94; today's close sits at 89% of that range, 6.4% below the 52-week high.
VIR bull case vs bear case (from the data)
- Price is +9.4% vs its 200-day average — above the long-term trend line.
- Price is -4.1% vs its 50-day average — short-term trend is down.
- Annual revenue fell 7.6% in the latest fiscal year (SEC XBRL).
- Latest fiscal-year net income: loss of $437.99M.
- Insider selling outweighs buying: 25 sales vs 0 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
- Share count up 21.8% in a year (dilution).
VIR latest news & SEC filings
Every SEC filing by or about VIR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.02 — Sold unregistered shares.
- Item 8.01 — Reported other events the company considers important.
Oct 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 6, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 17, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 9, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 25, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 24, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 21, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $238.95M (prior year $1.21M) (+19582.5% vs Jun 30, 2025)
- Net income: $80.08M (prior year -$110.96M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.47 (prior year -$0.80) (swung to profit vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade VIR
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 23, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.91% (largest 6.1%).
- Liquidity: about 1.98M shares (≈$20.17M) trade per day on average.
- 52-week position: $10.17 vs a range of $4.82–$12.00 (75% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Janet Napolitano sold 3,200 shares on Jun 1, 2026.
- Latest filings: 8-K Oct 14, 2026; 8-K Oct 8, 2026; 8-K Oct 1, 2026.
- Share count: 169.22M shares outstanding (Jul 29, 2026), +21.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
VIR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 10.07 | 10.23 | 9.96 | 10.17 | 361.38K |
| Oct 16, 2026 | 10.49 | 10.49 | 9.91 | 9.96 | 1.74M |
| Oct 15, 2026 | 10.38 | 10.67 | 10.20 | 10.47 | 1.42M |
| Oct 14, 2026 | 10.95 | 11.11 | 10.34 | 10.41 | 2.76M |
| Oct 13, 2026 | 11.21 | 11.25 | 10.60 | 10.61 | 1.78M |
| Oct 12, 2026 | 11.63 | 11.82 | 11.21 | 11.30 | 1.09M |
| Oct 9, 2026 | 11.11 | 12.00 | 10.97 | 11.70 | 1.97M |
| Oct 8, 2026 | 11.52 | 11.56 | 10.73 | 11.12 | 3.07M |
| Oct 7, 2026 | 11.32 | 11.77 | 11.32 | 11.52 | 3.56M |
| Oct 6, 2026 | 11.90 | 11.90 | 11.26 | 11.60 | 2.59M |
| Oct 5, 2026 | 11.17 | 11.87 | 10.92 | 11.78 | 3.15M |
| Oct 2, 2026 | 11.55 | 11.73 | 10.95 | 11.17 | 2.18M |
| Oct 1, 2026 | 10.86 | 11.61 | 10.86 | 11.29 | 2.58M |
| Sep 30, 2026 | 10.70 | 11.26 | 10.54 | 11.18 | 1.74M |
| Sep 29, 2026 | 10.49 | 10.85 | 10.34 | 10.65 | 1.57M |
| Sep 28, 2026 | 10.56 | 10.69 | 10.33 | 10.51 | 1.37M |
| Sep 25, 2026 | 10.82 | 10.82 | 10.48 | 10.66 | 1.13M |
| Sep 24, 2026 | 11.02 | 11.15 | 10.35 | 10.72 | 2.09M |
| Sep 23, 2026 | 11.44 | 11.53 | 10.85 | 11.09 | 1.68M |
| Sep 22, 2026 | 10.99 | 11.72 | 10.89 | 11.50 | 1.85M |
About Vir Biotechnology
Vir Biotechnology (VIR) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1706431.
VIR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Norbert W Bischofberger | Director | May 28, 2026 |
| Timothy Coughlin | Director | Jun 10, 2026 |
| Backer Marianne De | President and CEO | Apr 30, 2026 |
| Ramy Farid | Director | May 28, 2026 |
| Jeffrey S. Hatfield | Director | May 28, 2026 |
| Robert J More | Director | Aug 12, 2026 |
| Janet Napolitano | Director | Jun 2, 2026 |
| Vicki L Sato | Director | May 4, 2026 |
| Charles Elliott Sigal | Director | May 28, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Backer Marianne De | President and CEO | Apr 30, 2026 |
| Mark Eisner | EVP and Chief Medical Officer | Feb 26, 2026 |
| Jason O'Byrne | EVP & Chief Financial Officer | Mar 23, 2026 |
| Brent Sabatini | SVP, Chief Accounting Officer | Jun 2, 2026 |
| Verneuil Vanina De | EVP, General Counsel, Corp Sec | Feb 26, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 1, 2026 | Janet Napolitano | Sale | 3,200 | $9.45 |
| Jun 1, 2026 | Janet Napolitano | Sale | 3,200 | $9.45 |
| Jun 1, 2026 | Janet Napolitano | Sale | 3,200 | $9.45 |
| Jun 1, 2026 | Janet Napolitano | Sale | 3,200 | $9.45 |
| Jun 1, 2026 | Brent Sabatini | Sale | 379 | $9.45 |
| Jun 1, 2026 | Brent Sabatini | Sale | 379 | $9.45 |
| Jun 1, 2026 | Brent Sabatini | Sale | 379 | $9.45 |
| Jun 1, 2026 | Brent Sabatini | Sale | 379 | $9.45 |
| May 1, 2026 | Vicki L Sato | Sale | 22,000 | $10.05 |
| May 1, 2026 | Vicki L Sato | Sale | 22,000 | $10.05 |
| May 1, 2026 | Vicki L Sato | Sale | 22,000 | $10.05 |
| May 1, 2026 | Vicki L Sato | Sale | 22,000 | $10.05 |
| Apr 6, 2026 | Backer Marianne De | Sale | 72,559 | $9.16 |
| Apr 6, 2026 | Backer Marianne De | Sale | 72,559 | $9.16 |
| Apr 6, 2026 | Backer Marianne De | Sale | 72,559 | $9.16 |
VIR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $68.56M | $-437.99M | -3.16 | $-391.78M |
| Dec 31, 2024 | $74.20M | $-521.96M | -3.83 | $-446.35M |
| Dec 31, 2023 | $86.18M | $-615.06M | -4.59 | $-778.78M |
| Dec 31, 2022 | $1.62B | $515.84M | 3.83 | $1.66B |
| Dec 31, 2021 | — | $528.58M | 3.96 | $-47.59M |
Latest balance sheet: total assets $1.21B, total liabilities $232.31M, cash $278.73M (as of Jun 30, 2026).
VIR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $9.11 |
| May 6, 2026 | 8-K Item 2.02 (results) | $10.29 |
| Feb 23, 2026 | 8-K Item 2.02 (results) | $7.43 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $5.92 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $5.40 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $5.08 |
| May 7, 2025 | 8-K Item 2.02 (results) | $5.61 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $9.20 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $7.49 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 22, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on VIR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 11:42 AM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.